Byetta, Januvia, Janumet and Victoza are all diabetes treatments in a class of drugs known as incretin mimetics. Used to stabilize blood glucose levels in patients who suffer Type 2 diabetes, the medications have been linked to potentially life-threatening side effects including an increased risk of acute pancreatitis and pancreatic cancer. Since their launch on […]